Longboard Pharmaceuticals Stock Investor Sentiment

LBPH Stock  USD 18.67  1.23  7.05%   
Under 54% of Longboard Pharmaceuticals' traders are presently thinking to get in. The analysis of the overall investor sentiment regarding Longboard Pharmaceuticals suggests that some traders are interested. Longboard Pharmaceuticals' investor sentiment overview provides quick insight into current market opportunities from investing in Longboard Pharmaceuticals. The current market sentiment, together with Longboard Pharmaceuticals' historical and current headlines, can help investors time the market. In addition, many technical investors use Longboard Pharmaceuticals stock news signals to limit their universe of possible portfolio assets and to time the market correctly.
Longboard Pharmaceuticals stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Longboard daily returns and investor perception about the current price of Longboard Pharmaceuticals as well as its diversification or hedging effects on your existing portfolios.
  

Longboard Pharmaceuticals Sentiment by Major News Outlets

Investor sentiment, mood or attitude towards Longboard Pharmaceuticals can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.
few days ago at news.google.com         
Longboard Pharmaceuticals Trading Up 5.1 percent - MarketBeat
Google News at Macroaxis
few days ago at news.google.com         
Longboard Pharmaceuticals Buy Rating Reaffirmed at HC Wainwright - Defense World
Google News at Macroaxis
six days ago at news.google.com         
Technical Data - Stock Traders Daily
Google News at Macroaxis
over a week ago at news.google.com         
Short Interest in Longboard Pharmaceuticals, Inc. Increases By 32.4 percent - Defense World
Google News at Macroaxis
over a week ago at news.google.com         
Longboard Pharmaceuticals Receives Overweight Rating from Cantor Fitzgerald - Defense World
Google News at Macroaxis
over two weeks ago at finance.yahoo.com         
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Acade...
Yahoo News
over two weeks ago at businesswire.com         
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Acade...
businesswire News
over two weeks ago at investing.com         
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Acade...
Investing News at Macroaxis
over two weeks ago at businesswire.com         
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Acade...
businesswire News
over two weeks ago at businesswire.com         
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Acade...
businesswire News
over two weeks ago at businesswire.com         
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
over two weeks ago at businesswire.com         
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
over two weeks ago at businesswire.com         
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635
businesswire News
over two weeks ago at finance.yahoo.com         
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635
Yahoo News
over three weeks ago at simplywall.st         
Longboard Pharmaceuticals, Inc.s large institutional owners must be happy as stock continues to impr...
Simply Wall St News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Longboard Pharmaceuticals that are available to investors today. That information is available publicly through Longboard media outlets and privately through word of mouth or via Longboard internal channels. However, regardless of the origin, that massive amount of Longboard data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Longboard Pharmaceuticals news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Longboard Pharmaceuticals relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Longboard Pharmaceuticals' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Longboard Pharmaceuticals alpha.

Longboard Pharmaceuticals Performance against NYSE Composite

 Price Growth (%)  
       Timeline  
1
Sale by Arena Pharmaceuticals Inc of 78540 shares of Longboard Pharmaceuticals
01/29/2024
2
Longboard Pharmaceuticals Shares Gap Up to 23.15 - MarketBeat
01/31/2024
3
Acquisition by Kaye Randall of 17920 shares of Longboard Pharmaceuticals subject to Rule 16b-3
02/09/2024
4
Longboard Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635
03/01/2024
5
Longboard Pharmaceuticals Reports Full Year 2023 Financial Results and Provides Corporate Updates
03/12/2024
6
Longboard Pharmaceuticals Inc Reports Full Year 2023 Financial Results
03/14/2024
7
Longboard Pharmaceuticals, Inc. is a favorite amongst institutional investors who own 50
03/27/2024
8
Longboard Pharmaceuticals to Present Late-Breaking Data from the PACIFIC Study at the American Academy of Neurology Annual Meeting on April 15
04/03/2024
9
Short Interest in Longboard Pharmaceuticals, Inc. Increases By 32.4 percent - Defense World
04/15/2024
10
Longboard Pharmaceuticals Trading Up 5.1 percent - MarketBeat
04/18/2024
When determining whether Longboard Pharmaceuticals offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Longboard Pharmaceuticals' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Longboard Pharmaceuticals Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Longboard Pharmaceuticals Stock:
Check out Longboard Pharmaceuticals Hype Analysis, Longboard Pharmaceuticals Correlation and Longboard Pharmaceuticals Performance.
For more detail on how to invest in Longboard Stock please use our How to Invest in Longboard Pharmaceuticals guide.
You can also try the Crypto Correlations module to use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins.

Complementary Tools for Longboard Stock analysis

When running Longboard Pharmaceuticals' price analysis, check to measure Longboard Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Longboard Pharmaceuticals is operating at the current time. Most of Longboard Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Longboard Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Longboard Pharmaceuticals' price. Additionally, you may evaluate how the addition of Longboard Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Equity Search
Search for actively traded equities including funds and ETFs from over 30 global markets
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
Bond Analysis
Evaluate and analyze corporate bonds as a potential investment for your portfolios.
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Is Longboard Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Longboard Pharmaceuticals. If investors know Longboard will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Longboard Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(2.39)
Return On Assets
(0.58)
Return On Equity
(1.06)
The market value of Longboard Pharmaceuticals is measured differently than its book value, which is the value of Longboard that is recorded on the company's balance sheet. Investors also form their own opinion of Longboard Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Longboard Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Longboard Pharmaceuticals' market value can be influenced by many factors that don't directly affect Longboard Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Longboard Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Longboard Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Longboard Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.